While no conclusive evidence has been foundlinking RP11.611O2.6, ACPL2, and PGBD4P1 toclozapine-induced MetS, the current limitations of research do not rule out thepossibility of their involvement in antipsychotic drug-induced metabolicsyndrome. Here, PGBD4P1 is linked to metabolic syndrome.